SCHEMBL5041701

SCHEMBL5041701

CCOc1cc(C(OC)C(=O)NCc2ccc(C#N)cc2)c(F)cc1OCCO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.39
HIF1A Q16665 1/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
PKM P14618 1/20 0.38
ROCK2 O75116 1/20 0.37
ROCK1 Q13464 1/20 0.37
AKR1B1 P15121 1/20 0.36
BRD4 O60885 1/20 0.36
EPHX2 P34913 1/20 0.35
CTSD P07339 1/20 0.35
FAAH O00519 2/20 0.35
TSHR P16473 1/20 0.35
MAPK8 P45983 2/20 0.35
MAPK9 P45984 2/20 0.35
MAPK10 P53779 2/20 0.35
DYRK3 O43781 1/20 0.35
PRKD3 O94806 1/20 0.35
JUN P05412 1/20 0.35
CSF1R P07333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041703 1.00 GAA (0.39) GAAHIF1AKMT2AMEN1PKM
SCHEMBL5047694 0.87 HIF1A (0.47) HIF1AKMT2AMEN1PKMROCK2
SCHEMBL5047685 0.87 HIF1A (0.47) HIF1AKMT2AMEN1PKMROCK2
Hydrochloric Acid SCHEMBL5038299 0.83 F2 (0.48)
Hydrochloric Acid SCHEMBL5038289 0.83 F2 (0.48)
SCHEMBL5041188 0.81 MEN1 (0.39) GAAHIF1AKMT2AMEN1PKM
SCHEMBL5041195 0.81 MEN1 (0.39) GAAHIF1AKMT2AMEN1PKM
SCHEMBL5040796 0.81 PKM (0.41) HIF1APKMROCK2ROCK1EPHX2
SCHEMBL5037692 0.80 MEN1 (0.40) GAAHIF1AKMT2AMEN1PKM
SCHEMBL5037694 0.80 MEN1 (0.40) GAAHIF1AKMT2AMEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 GAA 1312/4885HIF1A 251/4885KMT2A 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.